These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31251764)

  • 21. Cigarette Smoking Attenuates Kidney Protection by Angiotensin-Converting Enzyme Inhibition in Nondiabetic Chronic Kidney Disease.
    Roehm B; Simoni J; Pruszynski J; Wesson DE
    Am J Nephrol; 2017; 46(4):260-267. PubMed ID: 28930715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
    BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electronic Cigarette Use During a Randomized Trial of Interventions for Smoking Cessation Among Medicaid Beneficiaries with Mental Illness.
    Bianco CL; Pratt SI; Ferron JC; Brunette MF
    J Dual Diagn; 2019; 15(3):184-191. PubMed ID: 31169077
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of Switching to the Tobacco Heating System 2.2 Menthol, Smoking Abstinence, or Continued Cigarette Smoking on Biomarkers of Exposure: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 1).
    Lüdicke F; Picavet P; Baker G; Haziza C; Poux V; Lama N; Weitkunat R
    Nicotine Tob Res; 2018 Jan; 20(2):161-172. PubMed ID: 28177489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual Users Compared to Smokers: Demographics, Dependence, and Biomarkers.
    Piper ME; Baker TB; Benowitz NL; Kobinsky KH; Jorenby DE
    Nicotine Tob Res; 2019 Aug; 21(9):1279-1284. PubMed ID: 30365010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk.
    King CC; Piper ME; Gepner AD; Fiore MC; Baker TB; Stein JH
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):374-379. PubMed ID: 27932354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When smokers quit: exposure to nicotine and carcinogens persists from thirdhand smoke pollution.
    Matt GE; Quintana PJE; Zakarian JM; Hoh E; Hovell MF; Mahabee-Gittens M; Watanabe K; Datuin K; Vue C; Chatfield DA
    Tob Control; 2016 Sep; 26(5):548-556. PubMed ID: 27655249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacology of eicosanoids, nicotine induced changes in man.
    Saareks V; Riutta A; Alanko J; Ylitalo P; Parviainen M; Mucha I; Sievi E; Vapaatalo H
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):631-42. PubMed ID: 11192937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotoxic impact of long-term cigarette and waterpipe smoking on DNA damage and oxidative stress in healthy subjects.
    Alsaad AM; Al-Arifi MN; Maayah ZH; Attafi IM; Alanazi FE; Belali OM; Alhoshani A; Asiri YA; Korashy HM
    Toxicol Mech Methods; 2019 Feb; 29(2):119-127. PubMed ID: 30273082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of Exposure and Potential Harm in Two Weeks of Smoking Abstinence: Changes in Biomarkers of Platelet Function, Oxidative Stress, and Inflammation.
    Makena P; Scott E; Chen P; Liu HP; Jones BA; Prasad GL
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
    Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
    J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.
    Schwedhelm E; Bartling A; Lenzen H; Tsikas D; Maas R; Brümmer J; Gutzki FM; Berger J; Frölich JC; Böger RH
    Circulation; 2004 Feb; 109(7):843-8. PubMed ID: 14757688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity.
    Valentine GW; Hefner K; Jatlow PI; Rosenheck RA; Gueorguieva R; Sofuoglu M
    J Dual Diagn; 2018; 14(1):2-13. PubMed ID: 29083287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers.
    Liu J; Liang Q; Frost-Pineda K; Muhammad-Kah R; Rimmer L; Roethig H; Mendes P; Sarkar M
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1760-9. PubMed ID: 21708936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2α, in biological samples by GC-MS or GC-MS/MS coupled with immunoaffinity column chromatography.
    Tsikas D; Suchy MT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():191-201. PubMed ID: 25583542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes.
    D'Ruiz CD; Graff DW; Robinson E
    BMC Public Health; 2016 Jul; 16():543. PubMed ID: 27401980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in biomarkers of endothelial function, oxidative stress, inflammation and lipids after smoking cessation: A cohort study.
    Colsoul ML; Goderniaux N; Onorati S; Dupuis S; Jamart J; Vanpee D; Berlin I; Galanti L
    Eur J Clin Invest; 2023 Aug; 53(8):e13996. PubMed ID: 37000021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial.
    Ellerbeck EF; Nollen N; Hutcheson TD; Phadnis M; Fitzgerald SA; Vacek J; Sharpe MR; Salzman GA; Richter KP
    JAMA Netw Open; 2018 Sep; 1(5):e181843. PubMed ID: 30646142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excretion of thromboxane metabolites in healthy women after cessation of smoking.
    Rångemark C; Ciabattoni G; Wennmalm A
    Arterioscler Thromb; 1993 Jun; 13(6):777-82. PubMed ID: 8499397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.